MAPS Act
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Overview
The Mapping America’s Pharmaceutical Supply Act (MAPS Act) aims to improve the coordination of federal efforts to identify and mitigate risks to the nation’s pharmaceutical supply chain. It establishes a list of essential medicines, requires a risk assessment of the supply chains for these medicines, and mandates mapping of the supply chains using data analytics. The bill also directs the Department of Defense to report on drug purchases from China and promotes data sharing among federal agencies to enhance supply chain security.
Key provisions
- Creates an ‘Essential Medicines List’ to identify critical drugs and active pharmaceutical ingredients.
- Requires a comprehensive risk assessment of the supply chains for medicines on the Essential Medicines List.
- Mandates mapping of pharmaceutical supply chains using data analytics to identify vulnerabilities.
- Directs the Department of Defense to report on drug purchases from China.
- Establishes a reporting requirement for the Secretary of Health and Human Services on supply chain mapping efforts.
- Calls for the use of advanced manufacturing technologies to bolster domestic production.
- Requires the consideration of cybersecurity threats within the supply chain risk assessment.
- Authorizes the Secretary to engage relevant industry in mapping efforts.
Who is affected
- Department of Health and Human Services
- Department of Defense
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
8 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours